본문 바로가기
KERD
논문KCI 등재

비만하지 않은 성인 남성에서 대사증후군의 대리 표지자로서 감마 글루타밀 전이효소의 임상적 유용성 평가

Evaluation of Clinical Usefulness of Gamma Glutamyl Transferase as a Surrogate Marker for Metabolic Syndrome in Non Obese Adult Men

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

본 연구는 대사증후군을 예측하는 대리 표지자로서 감마 글루타밀 전이효소(gamma glutamyl transferase, GGT)의 유용성을 평가하고자 하였다. 20세 이상의 비만하지 않은 남성 7,155명을 연구대상자로 하였다. 대사증후군 진단기준은 NCEP-ATP III (National Cholesterol Education Program - Third Adult Treatment Panel) 기준을 적용하였다. GGT에 따른 대사증후군 발병 위험도는 로지스틱 회귀분석을 적용하였으며, GGT의 대사증후군 위험 예측능력을 확인하기 위해 ROC (receiver operating characteristic) 곡선을 구하였다. 연령과 체질량지수와 무관하게 GGT 1사분위수보다 4사분위수에서 대사증후군 발병위험이 7.09배 높게 나타났다(p<0.001). 대사증후군 진단을 위한 GGT의 곡선아래면적(area under the curve)은 0.715였으며, GGT의 절단값(cut-off value)은 40.0 U/L, 민감도는 65.0%, 특이도 70.2%로 나타났다. 따라서 GGT는 대사증후군을 진단하기 위한 유용한 진단 지표로 판단된다.

Abstract

This study was to evaluate the usefulness of gamma glutamyl transferase (GGT) as a surrogate marker predicting metabolic syndrome. 7,155 non obese men over the age of 20 were studied as subjects. The criteria for diagnosing MetS were the National Cholesterol Education Program - Third Adult Treatment Panel (NCEP-ATP III). The risk of developing MetS according to GGT was conducted logistic regression analysis, and the ROC (receiver operating characteristic) curve was obtained to confirm GGT ability to predict the risk of MetS. Regardless of age and body mass index, MetS had a 7.09 times higher risk of onset in the fourth quartile than in the first quartile of GGT (p<0.001). The AUC (area under the curve) of GGT for the diagnosis of MetS was 0.715, and the cutoff value of GGT was 40.0 U/L, the sensitivity was 65.0%, and the specificity was 70.2%. Therefore, GGT is considered to be a useful diagnostic index for diagnosing MetS.

참고문헌 (44)

  1. Gjin Ndrepepa, "Gamma-glutamyl transferase and cardiovascular disease", Annals of Translational Medicine, 4(24), pp.481~481 (2016), AME Publishing Company[DOI]
  2. J. B. Whitfield, "Gamma Glutamyl Transferase", Critical Reviews in Clinical Laboratory Sciences, 38(4), pp.263~355 (2008), Informa UK Limited[DOI]
  3. Goya Wannamethee, "Gamma-glutamyltransferase: Determinants and Association with Mortality from Ischemic Heart Disease and All Causes", American Journal of Epidemiology, 142(7), pp.699~708 (1995), Oxford University Press (OUP)[DOI]
  4. D.-J. Kim, "Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors", Diabetic Medicine, 22(9), pp.1134~1140 (2005), Wiley[DOI]
  5. I. Abete, "Obesity and metabolic syndrome: Potential benefit from specific nutritional components", Nutrition, Metabolism and Cardiovascular Diseases, 21, pp.B1~B15 (2011), Elsevier BV[DOI]
  6. Christian K. Roberts, "Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome", Metabolism, 55(7), pp.928~934 (2006), Elsevier BV[DOI]
  7. EmanMokbel Alissa, "Relationship between serum gamma-glutamyltransferase activity and cardiometabolic risk factors in metabolic syndrome", Journal of Family Medicine and Primary Care, 7(2), pp.430~434 (2018), Medknow[DOI]
  8. D. E. Laaksonen, "Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study", American Journal of Epidemiology, 156(11), pp.1070~1077 (2002)[DOI]
  9. B. Isomaa, "Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome", Diabetes Care, 24(4), pp.683~689 (2001), American Diabetes Association[DOI]
  10. Vera Regitz-Zagrosek, "Gender differences in the metabolic syndrome and their role for cardiovascular disease", Clinical Research in Cardiology, 95(3), pp.136~147 (2006), Springer Science and Business Media LLC[DOI]
  11. Jieli Lu, "Metabolic Syndrome among Adults in China - The 2010 China Noncommunicable Disease Surveillance", The Journal of Clinical Endocrinology & Metabolism, 102(2), pp.507~515 (2016), The Endocrine Society[DOI]
  12. Isabelle Lemieux, "Elevated C-Reactive Protein", Arteriosclerosis, Thrombosis, and Vascular Biology, 21(6), pp.961~967 (2001), Ovid Technologies (Wolters Kluwer Health)[DOI]
  13. Jérôme Lugrin, "The role of oxidative stress during inflammatory processes", Biological Chemistry, 395(2), pp.203~230 (2014), Walter de Gruyter GmbH[DOI]
  14. Masahide Hamaguchi, "The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease", Annals of Internal Medicine, 143(10), pp.722~728 (2005), American College of Physicians[DOI]
  15. J Hung, "Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity", International Journal of Obesity, 32(5), pp.772~779 (2008), Springer Science and Business Media LLC[DOI]
  16. Maria Franzini, "Association between plasma gamma-glutamyltransferase fractions and metabolic syndrome among hypertensive patients", Scientific Reports, 7(1), pp.12003~ (2017), Springer Science and Business Media LLC[DOI]
  17. M LAFONTAN, "Role of adipokines in the control of energy metabolism: focus on adiponectin", Current Opinion in Pharmacology, 6(6), pp.580~585 (2006), Elsevier BV[DOI]
  18. Lixin Tao, "Association between γ-Glutamyl Transferase and Metabolic Syndrome: A Cross-Sectional Study of an Adult Population in Beijing", International Journal of Environmental Research and Public Health, 10(11), pp.5523~5540 (2013), MDPI AG[DOI]
  19. Yang Ho Kang, "The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults", Diabetes Research and Clinical Practice, 77(2), pp.306~313 (2007), Elsevier BV[DOI]
  20. 서병성, "The Association between Serum Gamma- Glutamyltransferase within Normal Levels and Metabolic Syndrome in Office Workers: A 4-Year Follow-up Study", Korean Journal of Family Medicine, 33(1), pp.51~58 (2012), 대한가정의학회
  21. Diana Zaineff Banderas, "γ-Glutamyl transferase", European Journal of Gastroenterology & Hepatology, 24(7), pp.805~810 (2012), Ovid Technologies (Wolters Kluwer Health)[DOI]
  22. R. A. DeFronzo, "Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease", Diabetes Care, 14(3), pp.173~194 (1991), American Diabetes Association[DOI]
  23. Giulio Marchesini, "NASH: From liver diseases to metabolic disorders and back to clinical hepatology", Hepatology, 35(2), pp.497~499 (2002), Wiley[DOI]
  24. Gulbanu Erkan, "The relationship between insülin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study", The Turkish Journal of Gastroenterology, 25(1), pp.63~68 (2015), AVES Publishing Co.[DOI]
  25. Kayoung Lee, "Which Liver Enzymes Are Better Indicators of Metabolic Syndrome in Adolescents: The Fifth Korea National Health and Nutrition Examination Survey, 2010", Metabolic Syndrome and Related Disorders, 11(4), pp.229~235 (2013), Mary Ann Liebert Inc[DOI]
  26. The Asia-Pacific perspective: redefining obesity and its treatment, "World Health Organization", Health Communications Australia, ~ (2000)
  27. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)", JAMA: The Journal of the American Medical Association, 285(19), pp.2486~2497 (2001), American Medical Association (AMA)[DOI]
  28. Douglas S. Lee, "Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk", Arteriosclerosis, Thrombosis, and Vascular Biology, 27(1), pp.127~133 (2007), Ovid Technologies (Wolters Kluwer Health)[DOI]
  29. Yu XU, "Cross-sectional and longitudinal association of serum alanine aminotransaminase and γ-glutamyltransferase with metabolic syndrome in middle-aged and elderly Chinese people", Journal of Diabetes, 3(1), pp.38~47 (2011), Wiley[DOI]
  30. An-Chun Hwang, "Synergistic effect of gamma glutamyltransferase and obesity on metabolic syndrome, independent of hepatic steatosis", Annals of Epidemiology, 22(12), pp.876~880 (2012), Elsevier BV[DOI]
  31. M. Y. Lee, "Relationship between γ-glutamyltransferase and metabolic syndrome in a Korean population", Diabetic Medicine, 25(4), pp.469~475 (2008), Wiley[DOI]
  32. Onni Niemelä, "Biomarker-Based Approaches for Assessing Alcohol Use Disorders", International Journal of Environmental Research and Public Health, 13(2), pp.166~ (2016), MDPI AG[DOI]
  33. 신경아, "성인 남성에서 체질량지수로 분류한 비만 유형에 따른 혈청 감마글루타밀 전이효소와 혈청 요산농도의 차이 비교", 대한임상검사과학회지, 51(1), pp.50~56 (2019), 대한임상검사과학회[DOI]
  34. Melanie Penke, "Non-alcoholic fatty liver disease in children and adolescents", Journal of Pediatric Endocrinology and Metabolism, 29(12), pp.1329~1330 (2016), Walter de Gruyter GmbH[DOI]
  35. Mehmet Boyraz, "Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria", Obesity Research & Clinical Practice, 8(4), pp.e356~e363 (2014), Elsevier BV[DOI]
  36. Mirja Tiikkainen, "Liver-Fat Accumulation and Insulin Resistance in Obese Women with Previous Gestational Diabetes", Obesity Research, 10(9), pp.859~867 (2002), Wiley[DOI]
  37. M. Adiels, "Overproduction of large VLDL particles is driven by increased liver fat content in man", Diabetologia, 49(4), pp.755~765 (2006), Springer Science and Business Media LLC[DOI]
  38. Duk-Hee Lee, "ReviewIs Serum Gamma Glutamyltransferase a Marker of Oxidative Stress?", Free Radical Research, 38(6), pp.535~539 (2009), Informa UK Limited[DOI]
  39. Paul M Ridker, "Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?", Circulation, 109(23), pp.2818~2825 (2004), Ovid Technologies (Wolters Kluwer Health)[DOI]
  40. Arthur Kerner, "Association Between Elevated Liver Enzymes and C-Reactive Protein", Arteriosclerosis, Thrombosis, and Vascular Biology, 25(1), pp.193~197 (2005), Ovid Technologies (Wolters Kluwer Health)[DOI]
  41. Jae-Min Park, "Serum γ-glutamyltransferase level and metabolic syndrome in children and adolescents: Korean National Health and Nutrition Examination Survey", Journal of Diabetes Investigation, 9(3), pp.522~528 (2018), Wiley[DOI]
  42. B. Kasapoglu, "Role of GGT in diagnosis of metabolic syndrome : a clinic-based cross-sectional survey", Indian Journal of Medical Research, 132, pp.56~61 (2010)
  43. Kyoungho Lee, "Increasing risk of diabetes mellitus according to liver function alterations in electronic workers", Journal of Diabetes Investigation, 5(6), pp.671~676 (2014), Wiley[DOI]
  44. Sangsu Lee, "Serum Gamma-Glutamyltransferase Levels are Associated With Concomitant Cardiovascular Risk Factors in Korean Hypertensive Patients", Medicine, 94(50), pp.e2171~ (2015), Ovid Technologies (Wolters Kluwer Health)[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (30건)